The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer’s disease biomarkers in down syndrome

To gain further knowledge on the preclinical phase of Alzheimer’s disease (AD), we sought to characterize cognitive performance, neuroimaging and plasma-based AD biomarkers in a cohort of non-demented adults with down syndrome (DS). The goal of the down syndrome biomarker Initiative (DSBI) pilot is...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Behav Neurosci
Autors principals: Rafii, Michael S., Wishnek, Hannah, Brewer, James B., Donohue, Michael C., Ness, Seth, Mobley, William C., Aisen, Paul S., Rissman, Robert A.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2015
Matèries:
Neuroscience
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4568340/
https://ncbi.nlm.nih.gov/pubmed/26441570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnbeh.2015.00239
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars